View in EDS HTML Full Text PDF Full Text

Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.

Saved in:

Bibliographic Details
Title:	Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.
Authors:	Ku, Jennifer H¹ (AUTHOR), Qian, Lei² (AUTHOR), Sy, Lina S² (AUTHOR), Ackerson, Bradley K² (AUTHOR), Rayens, Emily² (AUTHOR), Luo, Yi² (AUTHOR), Qiu, Sijia² (AUTHOR), Xu, Lanfang³ (AUTHOR), Lee, Gina S² (AUTHOR), Modha, Punam P² (AUTHOR)
Source:	Open Forum Infectious Diseases. May2026, Vol. 13 Issue 5, p1-4. 4p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	23288957
DOI:	10.1093/ofid/ofag279